RxDoctor Payments Data

Jacob Callison

Physician Assistant · Broken Arrow, OKNPI 1487885877

Payments from drug & device makers

$6,827in general payments, 2019–2025

Across 508 payments — averaging $13.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$549
  • Pfizer$460
  • Novo Nordisk$307
  • Lilly USA, LLC$305
  • Antares Pharma, Inc.$258
  • plus $3K from 33 others

What the payments were for

  • Food & beverage$6,796100%
  • Education$320%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,827 in reported general payments places this provider in the 90th percentile of 1,491 physician assistant providers in Oklahoma.

See all physician assistant providers in Oklahoma

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide36$45,268
FarxigaDapagliflozin Propanediol11$10,539
Gabapentin23$702
Testosterone Cypionate32$604
Omeprazole21$442
Rosuvastatin Calcium33$371
Trazodone Hcl22$317
Promethazine Hcl18$257
Duloxetine Hcl12$240
Lisinopril48$235
Metformin Hcl ErMetformin Hcl41$235
Clonazepam18$223
Venlafaxine Hcl ErVenlafaxine Hcl16$202
Baclofen15$198
Levothyroxine Sodium24$195

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$305$45,26836 claims
AstraZenecaFarxiga$549$10,53911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,491 physician assistant providers in Oklahoma.

Other physician assistant in Broken Arrow

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →